Synthetic Rat V1a Vasopressin Receptor Fragments Interfere with Vasopressin Binding via Specific Interaction with the Receptor

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1978 • 4,673 citations

Isolation of an organ specific protein antigen from cell-surface membrane rat liver

1968 • 883 citations

A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation

1996 • 758 citations

Hamster preproglucagon contains the sequence of glucagon and two related peptides

1983 • 602 citations

PyBOP®: A new peptide coupling reagent devoid of toxic by-product

1990 • 599 citations

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

1992 • 519 citations

Molecular cloning and expression of a rat Via arginine vasopressin receptor

1992 • 475 citations

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors

1992 • 415 citations

Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.

1994 • 368 citations

Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.

1991 • 330 citations

Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.

1993 • 321 citations

Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

1986 • 262 citations

The Binding Site of Neuropeptide Vasopressin V1a Receptor

1995 • 254 citations

[Progress in endocrinology].

1988 • 248 citations

Disulfide structures of highly bridged peptides: A new strategy for analysis

1993 • 204 citations

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

1995 • 174 citations

(³H)-Vasopressin Binding to Isolated Rat Hepatocytes and Liver Membranes: Regulation by GTP and Relation to Glycogen Phosphorylase Activation

1980 • 163 citations

Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect.

1995 • 121 citations

Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.

1978 • 121 citations

In vivo assembly of rhodopsin from expressed polypeptide fragments.

1995 • 103 citations

Structure of Glucagon-Like Peptide(7-36) Amide in a Dodecylphosphocholine Micelle as Determined by 2D NMR

1994 • 102 citations

Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states.

1983 • 100 citations

Tritium labelling of 8‐lysine vasopressin and its purification by affinity chromatography on sepharose bound neurophysins

1972 • 84 citations

The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor.

1984 • 82 citations

Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides

1993 • 78 citations

Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor

1993 • 78 citations

Identification of hormone-binding regions of the luteinizing hormone/human chorionic gonadotropin receptor using synthetic peptides.

1992 • 62 citations

5-Hydroxytryptamine1A receptor synthetic peptides. Mechanisms of adenylyl cyclase inhibition

1994 • 62 citations

Characterization of the Regulatory Domain of Gizzard Calponin

1995 • 58 citations

Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells

1986 • 55 citations

Oxytocin: Cellular and Molecular Approaches in Medicine and Research

1994 • 49 citations

Solubilization of the [8-lysine]vasopressin receptor and adenylate cyclase from pig kidney plasma membranes.

1975 • 45 citations

Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors

1996 • 35 citations

Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumour-cell line

1986 • 33 citations

Novel approach to the design of synthetic radioiodinated linear V_1A receptor antagonists of vasopressin

1992 • 29 citations

Application of electrospray ionization mass spectrometry with maximum‐entropy analysis to allelic ‘fingerprinting’ of major urinary proteins

1993 • 27 citations

A New Series of Photoactivatable and Iodinatable Linear Vasopressin Antagonists

1994 • 23 citations

The structure of α- and β-adrenergic receptors

1983 • 21 citations

Differential inactivation of vasopressin receptor subtypes in isolated membranes and intact cells by N‐ethylmaleimide

1990 • 20 citations

Identification of regions of the follitropin (FSH) β-subunit that interact with the N-terminus region (residues 9–30) of the FSH receptor

1993 • 20 citations

A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factorin vitro

1991 • 17 citations

Continuous flow synthesis of a biologically active small protein and a large peptide.

1992 • 14 citations

Synthesis of biotinylated and photoreactive probes for angiotensin receptors

1990 • 8 citations

Endothelin receptor synthetic N-terminal fragment interacts with the receptor itself

1996 • 1 citations